Original air date: April 17, 2013
In an effort to control the high cost of prescription drugs, it’s become commonplace for insurance companies to mandate that patients first try a generic drug before they’ll pay for a name-brand. Pharmaceutical companies don’t like this practice and increasingly doctors say it’s putting patients at risk. We take a closer look at a bill moving through the New Hampshire State House that seeks to curtail what’s known as step-therapy.